ISpecimen Profit Margin 2020-2025 | ISPC
Current and historical gross margin, operating margin and net profit margin for ISpecimen (ISPC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ISpecimen net profit margin as of September 30, 2025 is -343.86%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.009B |
| iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.580B | 31.14 |
| HCA Healthcare (HCA) | United States | $106.416B | 17.62 |
| CVS Health (CVS) | United States | $104.957B | 12.07 |
| Elevance Health (ELV) | United States | $82.726B | 12.13 |
| Cencora (COR) | United States | $68.377B | 22.04 |
| Natera (NTRA) | United States | $33.600B | 0.00 |
| DiDi Global (DIDIY) | China | $23.532B | 21.74 |
| Labcorp Holdings (LH) | United States | $22.381B | 17.07 |
| Medpace Holdings (MEDP) | United States | $17.078B | 42.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.157B | 0.00 |
| Viatris (VTRS) | United States | $15.249B | 5.68 |
| ICON (ICLR) | Ireland | $15.081B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.921B | 13.51 |
| Revvity (RVTY) | United States | $13.350B | 24.58 |
| CochLear (CHEOY) | Australia | $12.343B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.026B | 21.24 |
| Avantor (AVTR) | United States | $8.345B | 12.75 |
| Sonic Healthcare (SKHHY) | Australia | $7.987B | 0.00 |
| HealthEquity (HQY) | United States | $7.383B | 27.61 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.209B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.089B | 39.98 |
| PACS (PACS) | United States | $5.503B | 33.47 |
| Sotera Health (SHC) | United States | $5.369B | 25.89 |
| Alignment Healthcare (ALHC) | United States | $4.724B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.945B | 51.72 |
| Concentras Parent (CON) | United States | $2.785B | 17.38 |
| Organon (OGN) | United States | $2.532B | 2.67 |
| Progyny (PGNY) | United States | $2.155B | 42.37 |
| Surgery Partners (SGRY) | United States | $2.044B | 26.33 |
| Establishment Labs Holdings (ESTA) | United States | $1.960B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.907B | 11.39 |
| Ardent Health (ARDT) | United States | $1.236B | 4.03 |
| Nutex Health (NUTX) | United States | $1.127B | 8.62 |
| Teladoc Health (TDOC) | United States | $1.127B | 0.00 |
| CareDx (CDNA) | United States | $1.081B | 17.66 |
| Omada Health (OMDA) | United States | $0.930B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.872B | 14.28 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.715B | 4.07 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.685B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.596B | 0.00 |
| Enhabit (EHAB) | United States | $0.560B | 25.16 |
| CryoPort (CYRX) | United States | $0.547B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.489B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.419B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.311B | 65.42 |
| Shoulder Innovations (SI) | United States | $0.310B | 0.00 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.174B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.088B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.55 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |